RESUMEN

PURPOSE: The poor outcomes in glioblastoma necessitate new therapeutic target. Isoprenylcysteine carboxyl methyltransferase (ICMT), a unique enzyme of the final step of prenylation that modifies activities of oncogenic proteins, represents a promising target for many cancers. METHODS: Expression pattern, function and downstream pathway of ICMT in glioblastoma were analyzed using immunohistochemistry, ELISA, cellular assays and immunoblotting method. Combinatory effect was analyzed using Chou-Talalay approach. RESULTS: Upregulation of ICMT expression is a common phenomenon in glioblastoma patients regardless of clinicopathological characteristics. Gain-of-function and loss-of-function analysis support the role of ICMT in glioblastoma growth and survival but not migration. Importantly, pharmacological inhibitors of ICMT are effectively against glioblastoma cells while sparing normal neuron cells, and furthermore that they act synergistically with chemotherapeutic drugs. Consistently, ICMT inhibitor UCM-1336 significantly inhibits glioblastoma growth without causing toxicity in mice. Mechanistic studies demonstrate that Ras/Raf/Mek/Erk rather than Ras/PI3K/Akt/mTOR is the downstream pathway of ICMT-mediated glioblastoma growth. CONCLUSIONS: Our findings provide the proof-of-concept of pharmacologically targeting ICMT in the treatment of glioblastoma via deactivation of Ras/Raf/Mek/Erk.

Asunto(s)

Glioblastoma , Animales , Línea Celular Tumoral , Glioblastoma/tratamiento farmacológico , Humanos , Ratones , Fosfatidilinositol 3-Quinasas , Proteína Metiltransferasas/análisis , Proteína Metiltransferasas/metabolismo

RESUMEN

Isoprenylcysteine carboxylmethyltransferase (Icmt) which catalyzes the final step of prenylation of many oncoproteins, such as Ras. Despite studies on Icmt and its regulation in biological activities of various cancers, little is known on the expression, function and mechanisms of the impact of Icmt on hepatocellular carcinoma (HCC). We report here the findings that Icmt is critical for HCC growth, migration, survival and chemoresistance by multiple oncogenic pathways. Expression analysis on primary patient and cell line samples demonstrated that Icmt protein level was significantly higher in the majority (∼70%) of HCC tissues and cells than corresponding normal counterparts. Icmt depletion inhibited growth, survival and migration in HCC cells, and augmented the inhibitory effects of doxorubicin. Consistently, Icmt also inhibited growth, and migration, and induced apoptosis in HCC cells that are resistant to doxorubicin. In contrast, Icmt overexpression promoted growth and migration in normal liver cells. Mechanistically, Icmt inhibition suppressed Ras/Raf/Mek/Erk signaling and epithelial-mesenchymal transition (EMT) in HCC cells. Several different approaches demonstrated that Icmt was critical for HCC biological activities with the predominant role in cell response to chemotherapy. This previously unappreciated function of Icmt can be targeted to enhance chemotherapy in particular those HCC patients with high Icmt expression.

Asunto(s)

Carcinoma Hepatocelular/metabolismo , Neoplasias Hepáticas/metabolismo , Proteína Metiltransferasas/metabolismo , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Carcinoma Hepatocelular/tratamiento farmacológico , Carcinoma Hepatocelular/patología , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Resistencia a Antineoplásicos , Transición Epitelial-Mesenquimal/efectos de los fármacos , Humanos , Neoplasias Hepáticas/tratamiento farmacológico , Neoplasias Hepáticas/patología , Proteína Metiltransferasas/análisis , Transducción de Señal/efectos de los fármacos

RESUMEN

Inhibition of isoprenylcysteine carboxylmethyltransferase (Icmt), which catalyzes the final step of oncoproteins' prenylation, targets growth and survival of various cancers. In this work, we systematically studied the expression, functions and molecular signaling of Icmt in ovarian cancer. We show that the upregulation of Icmt expression is a common feature in patients with epithelial ovarian cancer regardless of age and disease stage. In line with the observations in ovarian cancer patients, a panel of epithelial ovarian cancer cell lines also demonstrates the significant increase on Icmt transcript and protein levels than normal ovarian epithelial cells. In addition, ovarian cancer cell lines with higher Icmt levels are more resistant to chemotherapeutic agents. We further show that Icmt inhibition by siRNA or inhibitor cysmethynil suppresses growth and induces apoptosis in ovarian cancer cells. Importantly, Icmt inhibition significantly augments chemotherapeutic agent's efficacy in vitro and in vivo, demonstrating the translational potential of Icmt inhibition in ovarian cancer. Mechanistically, we show that Ras activation is a critical effector of Icmt in ovarian cancer cells. Using cell culturing system, mouse model and patient samples, our work is the first to demonstrate the essential roles of Icmt in ovarian cancer via Ras signaling, particularly on its response to chemotherapy. Our findings suggest that Icmt inhibition is a promising therapeutic strategy to overcome chemoresistance in ovarian cancer, in particular, those patients with high Icmt expression.

Asunto(s)

Antineoplásicos/farmacología , Neoplasias Glandulares y Epiteliales/tratamiento farmacológico , Neoplasias Glandulares y Epiteliales/metabolismo , Neoplasias Ováricas/tratamiento farmacológico , Neoplasias Ováricas/metabolismo , Proteína Metiltransferasas/metabolismo , Proteínas ras/metabolismo , Animales , Apoptosis/efectos de los fármacos , Carcinoma Epitelial de Ovario , Línea Celular Tumoral , Femenino , Humanos , Indoles/farmacología , Ratones , Ratones Endogámicos NOD , Ratones SCID , Neoplasias Glandulares y Epiteliales/patología , Neoplasias Ováricas/patología , Proteína Metiltransferasas/análisis , Proteína Metiltransferasas/antagonistas & inhibidores

RESUMEN

INTRODUCTION: Nowadays, 40 % of early-stage NSCLC patients relapse in the 2 years following resection, suggesting a mis-staging in this group of patients who are not receiving adjuvant chemotherapy. Although different biomarkers, such as ERCC1, RRM1 and BRCA1 have been found to present prognostic value in advanced NSCLC patients, in early-stage NSCLC patients its relevance remains unclear. Moreover, SETDB1 has been recently proposed as a bona fide oncogene in lung tumourigenesis and related with metastasis. The aim of the present study was to analyze the prognostic value of ERCC1, RRM1, BRCA1 and SETDB1 expression levels in NSCLC patients at stage I. PATIENTS AND METHODS: ERCC1, RRM1, BRCA1 and SETDB1 expression at mRNA level was analyzed by real-time quantitative RT-PCR in fresh-frozen tumor and normal adjacent lung tissue samples from 64 stage I NSCLC patients. Later, significant association between gene expression levels, clinicopathological characteristics and patient's disease-free survival was assessed. RESULTS: We did not find any statistically significant correlation between gene expression and gender, age, histological type or smoking status. Univariate followed by multivariate Cox analysis showed that higher levels of BRCA1 and SETDB1 expression were significantly associated with shorter disease-free survival in stage I NSCLC patients. CONCLUSION: Our study finds that ERCC1 and RRM1 are not independent prognostic factors of recurrence in stage I NSCLC patients. By contrast, BRCA1 and SETDB1 stand out as the most significant prognostic markers in this group of patients, appearing as promising tools to predict tumor recurrence in early-stage NSCLC patients.

Asunto(s)

Biomarcadores de Tumor/análisis , Carcinoma de Pulmón de Células no Pequeñas/patología , Neoplasias Pulmonares/patología , Recurrencia Local de Neoplasia/patología , Adulto , Anciano , Proteína BRCA1/análisis , Proteína BRCA1/biosíntesis , Carcinoma de Pulmón de Células no Pequeñas/metabolismo , Carcinoma de Pulmón de Células no Pequeñas/mortalidad , Proteínas de Unión al ADN/análisis , Proteínas de Unión al ADN/biosíntesis , Supervivencia sin Enfermedad , Endonucleasas/análisis , Endonucleasas/biosíntesis , Femenino , N-Metiltransferasa de Histona-Lisina , Humanos , Estimación de Kaplan-Meier , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/mortalidad , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/metabolismo , Recurrencia Local de Neoplasia/mortalidad , Pronóstico , Modelos de Riesgos Proporcionales , Proteína Metiltransferasas/análisis , Proteína Metiltransferasas/biosíntesis , Reacción en Cadena en Tiempo Real de la Polimerasa , Ribonucleósido Difosfato Reductasa , Proteínas Supresoras de Tumor/análisis , Proteínas Supresoras de Tumor/biosíntesis

RESUMEN

Posttranslational modifications of histones are considered as critical regulators of gene expression, playing significant role in the pathogenesis and progression of tumors. Trimethylation of histone 3 lysine 9 (H3K9me3), a repressed transcription mark, is mainly regulated by the histone lysine N-methyltransferases (HKMTs), SUV39H1 and SETDB1. The present study investigated the implication of these HKMTs in glioma progression. SUV39H1 and SETDB1 expression was upregulated in glioma cell lines (GOS-3, 1321N1, T98G, U87MG) and in glioma tissues compared to normal brain being positively correlated with grade and histological malignancy. Suppression by siRNA of the two HKMTs for 24 and 48 h resulted in significantly reduced proliferation of GOS-3 and T98G glioma cells with siSUV39H1 effects been most prominent. Furthermore, HKMTs knockdown-induced apoptosis with a high rate of apoptotic cells have been observed after siSUV39H1 and siSETDB1 for both cell lines. Additionally, suppression of the two HKMTs reduced cell migration and clonogenic ability of both glioma cell lines. Our results indicate overexpression of SETDB1 and SUV39H1 in gliomas. Treatments that alter HKMT expression affect the proliferative and apoptotic rates in glioma cells as well as their migratory and colony formation capacity. These data suggest that both HKMTs and especially SUV39H1 may serve as novel biomarkers for future therapeutic targeting of these tumors.

Asunto(s)

Astrocitoma/enzimología , Neoplasias Encefálicas/enzimología , Glioblastoma/enzimología , Metiltransferasas/fisiología , Proteínas de Neoplasias/fisiología , Proteína Metiltransferasas/fisiología , Proteínas Represoras/fisiología , Apoptosis/efectos de los fármacos , Astrocitoma/patología , Biomarcadores de Tumor , Neoplasias Encefálicas/patología , División Celular/efectos de los fármacos , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Inducción Enzimática , Glioblastoma/patología , N-Metiltransferasa de Histona-Lisina , Humanos , Lisina/química , Metilación , Metiltransferasas/análisis , Metiltransferasas/antagonistas & inhibidores , Clasificación del Tumor , Proteínas de Neoplasias/análisis , Proteínas de Neoplasias/antagonistas & inhibidores , Proteína Metiltransferasas/análisis , Proteína Metiltransferasas/antagonistas & inhibidores , Procesamiento Proteico-Postraduccional , Interferencia de ARN , ARN Interferente Pequeño/farmacología , Proteínas Represoras/análisis , Proteínas Represoras/antagonistas & inhibidores , Ensayo de Tumor de Célula Madre , Regulación hacia Arriba

RESUMEN

Setdb1/Eset, a histone lysine methyltransferase, is recruited by various transcription factors to modify local chromatin. The observation that Setdb1-null blastocysts fail to produce epiblast-lineage cells suggests a role for Setdb1 in generating mouse embryonic stem cells (mESCs). When examined in mouse zygotes, Setdb1 proteins appeared as dots at perinucleolar rims of pronuclei, with the dot-shaped signals more prominent in male pronuclei. Setdb1 signals were observed diffusely in the nucleus from the two-cell stage onward and, by the blastocyst, took a punctate form, away from nucleolus. Such varying expression patterns suggest its involvement in diverse biological processes at preimplantation stage. Setdb1 appeared in Oct4-positive cells of inner-cell-mass origin but not in trophectoderm-lineage cells in blastocyst outgrowths. Setdb1 co-immunoprecipitated with Oct4 in mESCs, and Setdb1 expression was markedly reduced upon retinoic acid-induced differentiation. These observations suggest that Setdb1 has an important role in maintaining the self-renewal of mESCs through collaboration with Oct4.

Asunto(s)

Embrión de Mamíferos/metabolismo , Proteína Metiltransferasas/genética , Animales , Blastocisto/química , Blastocisto/metabolismo , Diferenciación Celular , Nucléolo Celular/metabolismo , Embrión de Mamíferos/química , Células Madre Embrionarias/química , Células Madre Embrionarias/metabolismo , N-Metiltransferasa de Histona-Lisina , Masculino , Ratones , Proteína Metiltransferasas/análisis , Tretinoina/metabolismo , Cigoto/química , Cigoto/citología , Cigoto/metabolismo

RESUMEN

Two major limitations to achieve efficient homing endonuclease-stimulated gene correction using retroviral vectors are low frequency of gene targeting and random integration of the targeting vectors. To overcome these issues, we developed a reporter system for quick and facile testing of novel strategies to promote the selection of cells that undergo targeted gene repair and to minimize the persistence of random integrations and non-homologous end-joining events. In this system, the gene target has an I-SceI site upstream of an EGFP reporter; and the repair template includes a non-functional EGFP gene, the positive selection transgene MGMTP140K tagged with mCherry, and the inducible Caspase-9 suicide gene. Using this dual fluorescent reporter system it is possible to detect properly targeted integration. Furthermore, this reporter system provides an efficient approach to enrich for gene correction events and to deplete events produced by random integration. We have also developed a second reporter system containing MGMTP140K in the integrated target locus, which allows for selection of primary cells with the integrated gene target after transplantation. This system is particularly useful for testing repair strategies in primary hematopoietic stem cells. Thus, our reporter systems should allow for more efficient gene correction with less unwanted off target effects.

Asunto(s)

Endodesoxirribonucleasas/metabolismo , Marcación de Gen/métodos , Genes Reporteros , Línea Celular , Colorantes Fluorescentes/análisis , Genoma , Proteínas Fluorescentes Verdes/análisis , Proteínas Fluorescentes Verdes/genética , Células HEK293 , Humanos , Proteína Metiltransferasas/análisis , Proteína Metiltransferasas/genética

RESUMEN

Maintenance of the Golgi apparatus (GA) structure and function depends on Golgi matrix proteins. The posttranslational modification of Golgi proteins such as phosphorylation of members of the golgin and GRASP families is important for determining Golgi architecture. Some Golgi proteins including golgin-84 are also known to be methylated, but the function of golgin methylation remains unclear. Here, we show that the protein arginine methyltransferase 5 (PRMT5) localizes to the GA and forms complexes with several components involved in GA ribbon formation and vesicle tethering. PRMT5 interacts with the golgin GM130, and depletion of PRMT5 causes defects in Golgi ribbon formation. Furthermore, PRMT5 methylates N-terminal arginines in GM130, and such arginine methylation appears critical for GA ribbon formation. Our findings reveal a molecular mechanism by which PRMT5-dependent arginine methylation of GM130 controls the maintenance of GA architecture.

Asunto(s)

Autoantígenos/metabolismo , Aparato de Golgi/enzimología , Proteínas de la Membrana/metabolismo , Proteína Metiltransferasas/metabolismo , Arginina/metabolismo , Línea Celular Tumoral , Aparato de Golgi/química , Aparato de Golgi/ultraestructura , Humanos , Metilación , Proteína Metiltransferasas/análisis , Proteína Metiltransferasas/genética , Proteína-Arginina N-Metiltransferasas , Interferencia de ARN

RESUMEN

UHRF1 (ubiquitin-like, containing PHD and RING finger domains 1) is a multi-domain protein associated with cellular proliferation and epigenetic regulation. The UHRF1 binds to methylated CpG dinucleotides and recruits transcriptional repressors DNA methyltransferase 1 (DNMT1) and histone deacetylase 1 (HDAC1) through its distinct domains. However, the molecular basis of UHRF1-mediated transcriptional regulation via chromatin modifications is yet to be fully understood. Here we show that UHRF1 binds histone lysine methyltransferase G9a, and both are co-localized in the nucleus in a cell-cycle-dependent manner. Concurrent with the cell-cycle progression, gradual deposition of UHRF1 and G9a was observed, which mirrored H3K9me2 accumulation on chromatin. Murine Uhrf1-null embryonic stem (ES) cells displayed a reduced amount of G9a and H3K9me2 on chromatin. UHRF1 recruited and cooperated with G9a to inhibit the p21 promoter activity, which correlated with the elevated p21 protein level in both human UHRF1 siRNA-transfected HeLa cells and murine Uhrf1-null ES cells. Furthermore, endogenous p21 promoter remained bound to UHRF1, G9a, DNMT1 and HDAC1, and knockdown of UHRF1 impaired the association of all three chromatin modifiers with the promoter. Thus, our results suggest that UHRF1 may serve as a focal point of transcriptional regulation mediated by G9a and other chromatin modification enzymes.

Asunto(s)

Proteínas Potenciadoras de Unión a CCAAT/metabolismo , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/genética , Silenciador del Gen , Proteínas Nucleares/metabolismo , Proteína Metiltransferasas/metabolismo , Transcripción Genética , Animales , Proteínas Potenciadoras de Unión a CCAAT/análisis , Línea Celular , Cromatina/metabolismo , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/metabolismo , Células HeLa , Histona Metiltransferasas , N-Metiltransferasa de Histona-Lisina , Humanos , Ratones , Proteínas Nucleares/análisis , Regiones Promotoras Genéticas , Proteína Metiltransferasas/análisis , Ubiquitina-Proteína Ligasas

RESUMEN

BACKGROUND: Isoprenylcysteine carboxyl methyltransferase (Icmt) is the third of three enzymes that posttranslationally modify proteins that contain C-terminal CaaX motifs. The processing of CaaX proteins through this so-called prenylation pathway via a route initiated by addition of an isoprenoid lipid is required for both membrane targeting and function of the proteins. The involvement of many CaaX proteins such as Ras GTPases in oncogenesis and other aberrant proliferative disorders has led to the targeting of the enzymes involved in their processing for therapeutic development, necessitating a detailed understanding of the mechanisms of the enzymes. RESULTS: In this study, we have investigated the kinetic mechanism of recombinant human Icmt. In the reaction catalyzed by Icmt, S-adenosyl-L-methionine (AdoMet) provides the methyl group that is transferred to the second substrate, the C-terminal isoprenylated cysteine residue of a CaaX protein, thereby generating a C-terminal prenylcysteine methyl ester on the protein. To facilitate the kinetic analysis of Icmt, we synthesized a new small molecule substrate of the enzyme, biotin-S-farnesyl-L-cysteine (BFC). Initial kinetic analysis of Icmt suggested a sequential mechanism for the enzyme that was further analyzed using a dead end competitive inhibitor, S-farnesylthioacetic acid (FTA). Inhibition by FTA was competitive with respect to BFC and uncompetitive with respect to AdoMet, indicating an ordered mechanism with SAM binding first. To investigate the order of product dissociation, product inhibition studies were undertaken with S-adenosyl-L-homocysteine (AdoHcy) and the N-acetyl-S-farnesyl-L-cysteine methylester (AFCME). This analysis indicated that AdoHcy is a competitive inhibitor with respect to AdoMet, while AFCME shows a noncompetitive inhibition with respect to BFC and a mixed-type inhibition with respect to AdoMet. These studies established that AdoHcy is the final product released, and that BFC and AFCME bind to different forms of the enzyme. CONCLUSIONS: These studies establish that catalysis by human Icmt proceeds through an ordered sequential mechanism and provide a kinetic framework for analysis of specific inhibitors of this key enzyme.

Asunto(s)

Proteína Metiltransferasas/análisis , Proteína Metiltransferasas/farmacocinética , Animales , Línea Celular , Humanos , Cinética , Unión Proteica/fisiología , Proteínas Recombinantes/análisis , Proteínas Recombinantes/farmacocinética

Asunto(s)

Endopeptidasas/análisis , Proteína Metiltransferasas/análisis , Secuencia de Aminoácidos , Animales , Línea Celular , ADN Complementario/genética , ADN Complementario/aislamiento & purificación , Endopeptidasas/genética , Inhibidores Enzimáticos , Técnica del Anticuerpo Fluorescente , Humanos , Indicadores y Reactivos , Cinética , Membranas/enzimología , Datos de Secuencia Molecular , Proteína Metiltransferasas/antagonistas & inhibidores , Proteína Metiltransferasas/genética , Procesamiento Proteico-Postraduccional , Conteo por Cintilación , Homología de Secuencia de Aminoácido , Porcinos , Proteínas ras/metabolismo

RESUMEN

Protein L-isoaspartate (D-aspartate) O-methyltransferases (MTs; EC 2.1.1.77) can initiate the conversion of detrimental L-isoaspartyl residues in spontaneously damaged proteins to normal L-aspartyl residues. We detected this enzyme in 45 species from 23 families representing most of the divisions of the plant kingdom. MT activity is often localized in seeds, suggesting that it has a role in their maturation, quiescence, and germination. The relationship among MT activity, the accumulation of abnormal protein L-isoaspartyl residues, and seed viability was explored in barley (Hordeum vulgare cultivar Himalaya) seeds, which contain high levels of MT. Natural aging of barley seeds for 17 years resulted in a significant reduction in MT activity and in seed viability, coupled with increased levels of "unrepaired" L-isoaspartyl residues. In seeds heated to accelerate aging, we found no reduction of MT activity, but we did observe decreased seed viability and the accumulation of isoaspartyl residues. Among populations of accelerated aged seed, those possessing the highest levels of L-isoaspartyl-containing proteins had the lowest germination percentages. These results suggest that the MT present in seeds cannot efficiently repair all spontaneously damaged proteins containing altered aspartyl residues, and their accumulation during aging may contribute to the loss of seed viability.

Asunto(s)

Extractos Vegetales/farmacología , Plantas/enzimología , Proteína Metiltransferasas/análisis , Proteína Metiltransferasas/metabolismo , Semillas/enzimología , Brassica , Citosol/enzimología , Hordeum , Proteína D-Aspartato-L-Isoaspartato Metiltransferasa , Proteína Metiltransferasas/antagonistas & inhibidores , Semillas/fisiología , Especificidad de la Especie , Árboles

RESUMEN

We determined the DNA sequence of a 2,232-bp region immediately upstream of the pcm gene at 59 min on the Escherichia coli chromosome that encodes an L-isoaspartyl protein methyltransferase with an important role in stationary-phase survival. Two open reading frames of 477 and 1,524 bp were found oriented in the same direction as that of the pcm gene. The latter open reading frame overlapped the 5' end of the pcm gene by 4 bp. Coupled in vitro transcription-translation analysis of DNA containing the 1,524-bp open reading frame directly demonstrated the production of a 37,000-Da polypeptide corresponding to a RNA species generated from a promoter within the open reading frame. The deduced amino acid sequence showed no similarity to known protein sequences. To test the function of this gene product, we constructed a mutant strain in which a kanamycin resistance element was inserted at a BstEII site in the middle of its coding region in an orientation that does not result in reduction of Pcm methyltransferase activity. These cells were found to survive poorly in stationary phase, at elevated temperatures, and in high-salt media compared with parent cells containing the intact gene, and we thus designate this gene surE (survival). surE appears to be the first gene of a bicistronic operon also containing the pcm gene. The phenotypes of mutations in either gene are very similar and indicate that both gene products are important for the viability of E. coli cells under stressful conditions.

Asunto(s)

Fosfatasa Ácida , Proteínas Bacterianas/genética , Proteínas de Escherichia coli , Escherichia coli/crecimiento & desarrollo , Escherichia coli/genética , Genes Bacterianos/genética , Secuencia de Aminoácidos , Secuencia de Bases , Mapeo Cromosómico , Cromosomas Bacterianos , Calor/efectos adversos , Datos de Secuencia Molecular , Mutagénesis Insercional , Biosíntesis de Proteínas , Proteína D-Aspartato-L-Isoaspartato Metiltransferasa , Proteína Metiltransferasas/análisis , Proteína Metiltransferasas/genética , ARN Mensajero/genética , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido , Especificidad de la Especie , Transcripción Genética

RESUMEN

The specific activity of protein L-isoaspartyl methyltransferase, an enzyme implicated in the metabolism of damaged, isoaspartate-containing proteins, has been measured in postmortem samples of parietal cortex from 30 individuals (19 with Alzheimer's disease and 11 controls). Methyltransferase specific activity was positively correlated with age at death, increasing by 2.9 pmol/min/mg of protein for every ten years of age (r = .51, p less than 0.005). This correlation was significant in the control and Alzheimer's disease groups alike. Specific activity also appeared to be about 15% higher in females than in age- and diagnosis-matched males (p less than 0.05). No significant differences were observed between age- and sex-matched Alzheimer patients and controls, suggesting that a deficiency in this enzyme is not responsible for the accumulation of abnormal proteins in Alzheimer's disease.

Asunto(s)

Envejecimiento/metabolismo , Enfermedad de Alzheimer/enzimología , Encéfalo/enzimología , Proteína Metiltransferasas/análisis , Anciano , Anciano de 80 o más Años , Corteza Cerebral/enzimología , Femenino , Humanos , Masculino , Metilación , Persona de Mediana Edad , Proteína D-Aspartato-L-Isoaspartato Metiltransferasa , Factores Sexuales

RESUMEN

The short-term effects of a lipotrope-deficient (methyl-deficient) diet on tRNA and protein methyltransferase activities have been studied using pair-fed male Fischer rats. The activity of liver N2-guanine tRNA methyltransferase II (NMG2) of animals receiving the methyl-deficient diet (MDD) for 2 weeks was found to be elevated more than 2-fold. This is in agreement with the results of earlier experiments in which the animals were fed ad libitum. These data indicate that the effects of lipotrope-deficient diets on NMG2 activity observed in the earlier studies can be attributed to the nature of the diet, and not to differences in caloric intake. In the same pair-fed animals, very little effect of MDD on the activity of NMG2 of either brain or spleen was observed. In liver, the activity of one of the enzymes that catalyze protein methylation--protein methylase I (S-adenosyl-methionine: protein-arginine N-methyltransferase)--was significantly elevated in response to the lipotrope-deficient diet. In contrast, the activities of protein methylase II (S-adenosylmethionine: protein-carboxy-O-methyltransferase), from control and experimental animals did not differ significantly. Lipotrope-deficient diets are thus seen to induce, within a short period of time, selective changes in the activities of some, but not all, of the liver enzymes that catalyze the methylation of tRNA and protein.

Asunto(s)

Proteína Metiltransferasas/análisis , ARNt Metiltransferasas/análisis , Animales , Deficiencia de Colina/enzimología , Deficiencia de Ácido Fólico/enzimología , Masculino , Metionina/deficiencia , Metilación , Ratas , Ratas Endogámicas F344 , Deficiencia de Vitamina B 12/enzimología

RESUMEN

1. The protein-carboxyl methylating system has been studied in adrenal medullary cells either using disrupted cell components or with intact cells. Whereas the enzyme protein-carboxyl methylase (PCM) is cytosolic, the majority of its substrates is on or within chromaffin granules. With intact granules, methylation of surface proteins results in solubilization of membrane proteins. 2. Membrane PCM substrates have been identified as two proteins with apparent molecular weights of 55,000 and 32,000. Among the substrates located inside the granules, the chromogranins are excellent substrates, while dopamine beta-hydroxylase is poorly methylated. 3. Under physiological conditions, stimulation of the splanchnic nerve results in an increase in adrenal medullary protein-methyl ester formation as well as in an augmented methanol production. With adrenal medullary cells in culture, carboxyl-methylated chromogranin A is detected in mature chromaffin granules between 3 and 6 hr after labeling. Methylated chromogranins are secreted concomitantly with catecholamines following cholinergic stimulation. 4. These data coupled with those of Chelsky et al. (J. Biol. Chem. 262:4303-4309, 1987) on lamin B suggest that PCM methylates residues other than D-aspartyl and L-isoaspartyl in proteins. They further suggest that methylation may occur on nascent peptide chains before they are injected into the rough endoplasmic reticulum.

Asunto(s)

Médula Suprarrenal/enzimología , Proteína Metiltransferasas/análisis , Proteína O-Metiltransferasa/análisis , Médula Suprarrenal/metabolismo , Animales , Cromograninas/metabolismo , Citosol/enzimología , Humanos , Metilación , Peso Molecular , Proteína O-Metiltransferasa/fisiología

RESUMEN

Levels of protein-carboxyl methylase (PCM) activity were measured in spermatozoa from infertile patients with less than 50% sperm motility and compared with those of normal fertile controls. When spermatozoa were washed by a standard centrifugation procedure, the level of PCM activity in a subgroup of patients with sperm motility ranging from 0% and 20% (24.0 +/- 5.2 pmol/mg protein, mean +/- standard error of the mean) was significantly different from that of controls (35.9 +/- 2.3 pmol/mg). However, when the entire population of patients with sperm motility ranging from 0% to 50% (32.6 +/- 6.2 pmol/mg) was compared with controls, no significant difference was observed in sperm PCM levels. With this standard washing procedure no significant relationship (r = 0.28; P greater than 0.05) between sperm PCM activity and motility was observed. By contrast, when spermatozoa were washed on a Percoll gradient, to eliminate other cellular elements, both groups of patients with 0% to 20% (14.6 +/- 2.5 pmol/mg) and with 0% to 50% (21.5 +/- 2.4 pmol/mg) sperm motility had sperm PCM levels significantly lower than that of controls (34.7 +/- 3.6). A highly significant relationship (r = 0.78; P less than 0.001) was observed between the levels of sperm PCM activity and motility.

Asunto(s)

Proteína Metiltransferasas/análisis , Proteína O-Metiltransferasa/análisis , Motilidad Espermática , Espermatozoides/enzimología , Adulto , Estradiol/sangre , Hormona Folículo Estimulante/sangre , Humanos , Infertilidad Masculina/enzimología , Infertilidad Masculina/fisiopatología , Hormona Luteinizante/sangre , Masculino , Persona de Mediana Edad , Semen/citología , Testosterona/sangre , Varicocele/enzimología , Varicocele/fisiopatología

RESUMEN

The influence of various substances which are known to alter free intracellular calcium concentrations on protein carboxyl methyltransferase (PCM) activity was investigated in rat brain synaptosomes. The synaptosomes were labeled with L-[3H]methionine and the 3H-methyl esters of proteins were formed from the methyl donor S-[3H]adenosyl-L-methionine ([3H]AdoMet). The calcium ionophore A23187 and ouabain decreased PCM activity and the decrease produced by A23187 was antagonized by ethylene glycol bis(beta-aminoethyl ether)-N,N'-tetraacetic acid and MnCl2. On the other hand, ruthenium red, an inhibitor of calcium uptake, stimulated PCM activity. These data suggest that PCM activity is inversely related to the free cytoplasmic calcium concentration. Veratridine, A23187 and elevated potassium ions decreased the levels of ATP and [3H]AdoMet. The A23187-mediated decrease in ATP levels and the reduced [3H]AdoMet formation was antagonized by ethylene glycol bis(beta-aminoethyl ether)-N,N'-tetraacetic acid and MnCl2. Inhibition of metabolic activity of the synaptosomes by NaCN led to: decreased ATP levels; inhibition of [3H]AdoMet formation; and inhibition of PCM activity. These data suggest that the decrease in protein methylation produced by secretagogues is associated with an increase in the concentration of free intracellular calcium which results in a decrease in the metabolically active pool of ATP. This leads to a decreased rate of AdoMet formation, a cosubstrate for PCM and a resultant decrease in PCM activity.

Asunto(s)

Adenosina Trifosfato/análisis , Encéfalo/metabolismo , Cloruros , Compuestos de Manganeso , Proteína Metiltransferasas/análisis , Proteína O-Metiltransferasa/análisis , Proteínas/metabolismo , Sinaptosomas/metabolismo , Adenosina/análisis , Animales , Química Encefálica/efectos de los fármacos , Calcimicina/farmacología , Calcio/metabolismo , Ácido Egtácico/farmacología , Femenino , Técnicas In Vitro , Manganeso/farmacología , Metilación , Ouabaína/farmacología , Potasio/farmacología , Ratas , Ratas Endogámicas , Rojo de Rutenio/farmacología , S-Adenosilhomocisteína/análisis , S-Adenosilmetionina/análisis , S-Adenosilmetionina/metabolismo , Cianuro de Sodio/farmacología , Tritio , Veratridina/farmacología

RESUMEN

The physicochemical and molecular properties of testicular Protein Carboxyl Methylase (PCM) have been studied. The testicular enzyme was stable at high ionic strength, independent of metal ions and resistant to reducing or alkylating agents, and displayed a narrow pH optimum of pH 5.8-6.0. The enzyme had a molecular weight of approximately 25,000 daltons and a Km for S-adenosyl-L-methionine (SAM) of 1.3 microM. Varying concentrations of gelatine (exogenous methyl acceptor protein) did not change the affinity of the enzyme for SAM. The molecular properties of the enzyme were characterized using gel filtration, hydroxyapatite and DEAE-cellulose chromatography, and isoelectric focusing. Three charge isomers exhibiting PCM activity were isolated with pI values of 6.1, 6.7, and 7.35 while comparative data from the pituitary gland revealed primarily the presence of the most acid isozyme (pI 6.1). These results suggest that the different testicular charge isozymes may be involved in the selective methylation of specific testicular proteins.

Asunto(s)

Isoenzimas/análisis , Proteína Metiltransferasas/análisis , Proteína O-Metiltransferasa/análisis , Testículo/enzimología , Animales , Cinética , Masculino , Peso Molecular , Ratas , Ratas Endogámicas

Asunto(s)

Proteína Metiltransferasas/análisis , Proteína O-Metiltransferasa/análisis , Animales , Citosol/enzimología , Concentración de Iones de Hidrógeno , Riñón/enzimología , Cinética , Masculino , Ratas , Distribución Tisular